BDSX Stock Analysis: Buy, Sell, or Hold?
BDSX - Biodesix, Inc. Common Stock
$13.79
-0.42 (-2.96%)
▼
5d:
-6.13%
30d:
-10.05%
90d:
+102.2%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BDSX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BDSX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $13.79, which is considered slightly low relative to its 30-day fair value range of $13.65 to $17.69.
Technical Outlook: Technically, BDSX is in a strong uptrend. The price is currently testing key support at $13.56. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+111.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDSX is in a strong uptrend. The price is currently testing key support at $13.56. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+111.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$13.65 -
$17.69
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 111.1% below Wall St target ($30.00)
- CAUTION: Recommendation downgraded due to -6.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$13.65 -
$17.69
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$13.56
Resistance Level
$17.90
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.30
Wall Street Target
$30.00
(+111.1%)
Revenue Growth (YoY)
40.8%
Profit Margin
-39.9%
Share & Embed Analysis
Last updated: March 30, 2026 4:25 PM ET
Data refreshes hourly during market hours. Next update: 5:25 PM
Data refreshes hourly during market hours. Next update: 5:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Gary Anthony Pestano
SELL
556 shares
2026-02-23
Kieran O'kane
SELL
535 shares
2026-02-23
Robin Harper Cowie
SELL
535 shares
2026-02-23
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 61 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 54 HOLD |
